HRD effects on first-line adjuvant chemotherapy and PARPi maintenance therapy in Chinese ovarian cancer patients

por Li, Lei, Gu, Yu, Zhang, Mengpei, Shi, Xiaohua, Li, Zhe, Xu, Xinyun, Sun, Tianqi, Dong, Yu, Xue, Chao, Zhu, Xiaoru, Lv, Ran, Jiao, Kai, Ji, Xuwo, Wang, Li-juan, Zhang, Yang, Liang, Zhiyong, Jin, Ying, Yin, Rutie, Wu, Ming, Liang, Han
Publicado 2023